Weight & Measure

Is GLP-1 TikTok helping or hurting patients? Millions of people living with obesity turn to TikTok every day for information, support, motivation, and community. But as obesity management medications like Wegovy®, Zepbound®, Ozempic®, and Mounjaro® become increasingly common, social media has also become one of the most influential sources of obesity treatment information. So who is shaping the co...

EPISODE DESCRIPTION What happens when the obesity medicine physician is also living with obesity? In this episode of Weight & Measure, hosts Mike Donnelly-Boylen and Zach Niemiec are joined by Dr. Matthea Rentea, Dr. Catherine Toomer, and Dr. Brianna Bingham for an honest conversation about obesity, GLP-1 medications, bariatric surgery, weight stigma, and the realities of treating a disease wh...

You Lost the Weight. Now What? GLP 1 Maintenance, Mindset, and Long Term Success Many people focus on how to lose weight. Far fewer talk about what happens after. For many individuals using GLP 1 medications, pursuing Bariatric & Metabolic Surgery, or making significant lifestyle changes, reaching a goal weight is not the end of the journey. It is the beginning of a new challenge: maintaining...

Medicare, GLP 1s, and Fear: What Older Adults Need to Know | Angela Fitch, MD, Tracy Zvenyach, PhD, MS, RN, and Deb Cooperman As Medicare coverage for obesity treatment continues to evolve, many older adults are asking the same questions: Can Medicare cover GLP 1 medications like Wegovy or Zepbound? Who qualifies for the Medicare Bridge Program? What should adults over 65 know before starting obes...

GLP 1 and Bariatric and Metabolic Surgery Patients How Do You Become an Advocate What does it actually take to become a patient advocate in obesity care? In this episode of Weight and Measure, we bring together leading voices across obesity medicine, patient advocacy, and policy to explore how individuals move from lived experience to meaningful impact. As obesity continues to be recognized as a c...

GLP-1 not working like before? You’re not alone. Many people using GLP-1 medications such as Ozempic, Wegovy, or Mounjaro reach a point where weight loss slows, fatigue increases, and progress feels stalled. This phase is often referred to as a weight loss plateau, but it is frequently misunderstood. In this episode of Weight and Measure , we break down what is actually happening during this stage...

In this episode of Weight & Measure with Mike and Zach , we bring you a powerful conversation from one of our original live panels, now available in audio format. This discussion brings together patients, clinicians, and advocates for an honest, real-time conversation about how obesity is talked about, taught, and experienced. We are joined by an incredible group of voices across obesity care:...

In this special live episode of Weight and Measure , recorded from the Canadian Obesity Summit in Montréal, we explore a critical question in obesity care today: What does it actually look like when patients help shape the systems that affect their care? Zach and Mike are joined by leaders from Obesity Canada alongside patient advocates Lisa Schaffer, Patty Nece, and Ian Patton for a conversation...

In the first episode of Weight & Measure with Mike and Zach , we bring together patients, providers, and experts for an honest conversation about movement in the context of obesity, GLP-1 medications, and bariatric surgery . Movement is often misunderstood in weight loss and obesity care. For many, it has been shaped by stigma, shame, or the idea that exercise is punishment rather than support...